
Current Market Outlook
The repeated bouts of heavy-volume selling have driven the major indexes below their key 50-day moving averages, and that’s a clear sign that the bulls are not in control. We’re moving our Market Monitor down to a level 5 and advise you to hold a good chunk of cash on the sideline, cut back on new buying (keep any new positions much smaller than normal) and honor your stops. None of this is to say that we’re bearish—it’s certainly possible the market snaps back, as there’s plenty of pessimism and many liquid leaders are holding up well. But after weeks of sloppy action and distribution, the odds favor further downside in the near-term, and we’ll need to see a few strong days before concluding the overall uptrend is resuming.
This week’s list, though, has a bunch of resilient growth-oriented names, which is encouraging. Our Top Pick is
DXC Technology (DXC), which is the product of a recent merger and sports giant cash flow.
| Stock Name | Price | Buy Range | Loss Limit |
|---|
| Abiomed (ABMD) | 0.00 | 148-152 | 139-141 |
| Alibaba (BABA) | 254.81 | 156-166 | 145-150 |
| DXC Technology (DXC) | 0.00 | 82-84 | 76.5-78 |
| Insulet (PODD) | 175.69 | 52.5-54.5 | 48.5-50 |
| Kite Pharma (KITE) | 0.00 | 120-127 | 105-109 |
| Realpage (RP) | 0.00 | 40-42 | 37-38 |
| Red Hat (RHT) | 0.00 | 99-102 | 94.5-95.5 |
| Salesforce.com (CRM) | 0.00 | 89.5-92 | 84-85 |
| Stamps.com (STMP) | 0.00 | 198-210 | 177-184 |
| Weibo (WB) | 98.16 | 85-89 | 77-79 |